Research Nester has recently announced new market demand assessment research titled “Diabetic Footwear (Shoes) Market– Global Demand Analysis & Opportunity Outlook 2021”. The global market study provides a granular data and in-depth analysis on the current and future market situations that are crucial for the existing &new players in the market. The industry research is based on key factors like demand & supply analysis, commercial activities, research investments, pricing analysis, government initiatives & guidelines, driving forces in the market, roadblocks and segmentation based on the product viability.
The global market of diabetic footwear (shoes) is anticipated to flourish at a healthy compound annual growth rate (CAGR) of 8.27% during the forecast period i.e. 2015-2021. The global diabetic (therapeutic footwear, orthopedic shoes) market would majorly be driven by the rising prevalence of diabetes (in 20-79 years of age group) in the world.
Apart from rising prevalence of diabetes, rise in spending on diabetes treatment is yet another major growth driver of the diabetic footwear (shoes) market. The global spending on diabetes is projected to expand from USD 936 Billion in 2015 to USD 1,128 Billion by 2021. This rise in spending would definitely help the global diabetic footwear market in the coming 8-10 years of time.
Regionally, Asia Pacific region is anticipated to witness the highest growth in the diabetic footwear (shoes) market, with China being the largest market in the region followed by India during the forecast period i.e. 2015-2021. Growth in the aging population, strengthening economic condition, better GDP figures and increase in the per capita income are some of the major factors that would escalate the demand of diabetic footwear in the Asia Pacific region.
The global diabetic footwear or orthopedic shoes or therapeutic shoes market is segmented on the basis of demography, which depicts that women have higher tendency to purchase the diabetic footwear (shoes) than men. Owing to this tendency, the female diabetic footwear (68% share in 2014), occupies the largest market of diabetic footwear across the globe. However, owing to an increase in the total number of male diabetic patients in comparison to female diabetic patients in the world, there is a greater need of male diabetic footwear in the future.
In addition to demography, the orthopedic shoes market is also segmented by inpatients and outpatients and by retail distribution. The retail distribution is further segmented into on-line and off-line retail out of which, the on-line distribution channel with 71% share is anticipated to have the largest share by 2021. The major reason behind the growth of e-commerce channels can be attributed to rising penetration of smartphones and high speed internet services like 3G and 4G in the world.
DARCO International, Ortho Europe, Duna Srl, Thuasne, DJ Global, Hong Kong Grace Shoes, Dr. Zen Inc., Drew Shoe Corporation, and Podartis Srl are some of the major key players of the global diabetic footwear (orthopedic shoes) market.
- North America (U.S., Canada)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia Poland, Rest of Eastern Europe)
- Asia-Pacific (China, India, Singapore, Japan, Australia & New Zealand & Rest of Asia)
- Rest of World
To know more on coverage, click on the link below:-
Phone : U.S. +1 646 586 9123
U.K. +44 203 608 5919